Exponent Inc (NASDAQ:EXPO)
| Market Cap | $4.24B+25.9% |
| Revenue (ttm) | $659.07M+15.4% |
| Net Income | $114.67M+9.4% |
| EPS | $2.32+13.2% |
| Shares Out | 47.55M |
| PE Ratio | 38.43 |
| Forward PE | 32.85 |
| Dividend | $1.23(1.38%) |
| Ex-Dividend Date | Dec 4, 2026 |
| Volume | 534,132 |
| Open | $89.36 |
| Previous Close | $89.00 |
| Day's Range | $89.04 - $90.82 |
| 52-Week Range | $51.91 - $90.98 |
| Beta | 0.68 |
| Analysts | Buy |
| Price Target | $72.00(-19.25%) |
| Earnings Date | Feb 4, 2027 |
About EXPO
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation. The company, originally established in 1967 as The Failure Group, Inc., rebranded as Exponent, Inc. in 1998, and its headquarters are located in Menlo Park, California.
Exponent Inc Stock Analysis — InsiderScore
Exponent Inc scored higher than 20% of companies evaluated by InsiderBuying, and ranked 88th out of 106 stocks in the manufacturing sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at Exponent Inc bought $12.6K of stock across 1 purchase in the last 90 days, the largest of them $12.6K.
The average purchase added about 0% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
Every buyer already held stock, so each purchase is an increase rather than a first position.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
2 firms rating EXPO in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Dec 4, 2026Ex-dividend date
- Feb 4, 2027Earnings report
$EXPO stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of EXPO by members of U.S. Congress
| Lisa C. McClainHouse / R | Sale$1.00K – $15.00K | Sep 11, 2025 |
| Lisa C. McClainHouse / R | Purchase$1.00K – $15.00K | Aug 13, 2025 |
Recently reported changes in EXPO holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by EXPO's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
EXPO Estimated quarterly lobbying spending
Source: U.S. Senate LDA
EXPO Revenue by Segment or Geography
| Engineering and Other Scientific | $150.10M | 86.40% |
| Environmental and Health | $23.64M | 13.60% |
As of: Q4 2026 (Oct 2, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New EXPO patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to EXPO from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in EXPO
| IJHiShares Core S&P Mid-Cap ETF | $152.74M |
| IWMiShares Russell 2000 ETF | $117.20M |
| SDVYFirst Trust SMID Cap Rising Dividend Achievers ETF | $94.92M |
| VTIVanguard Morningstar Total Stock Market ETF | $93.60M |
| VBVanguard Morningstar Small-Cap ETF | $85.58M |
| PAVEGlobal X - U.S. Infrastructure Development ETF | $64.09M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from EXPO’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Insider Score Trend Over Time
+5.1 since Sep 24Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| FSML | Franklin Small Cap Enhanced ETF | 1.54% |
| ABLS | Abacus FCF Small Cap Leaders ETF | 1.50% |
| DGLO | First Trust Exchange-Traded Fund VI - First Trust RBA Deglobalization ETF | 1.18% |
| OUSM | ALPS O'Shares U.S. Small-Cap Quality Dividend ETF | 1.04% |
| DGRS | WisdomTree U.S. SmallCap Quality Dividend Growth Fund | 0.89% |
| SDVD | FT Vest SMID Rising Dividend Achievers Target Income ETF | 0.81% |
| SDVY | First Trust SMID Cap Rising Dividend Achievers ETF | 0.81% |
| MCOW | Pacer Funds Trust - Pacer S&P MidCap 400 Quality FCF Aristocrats ETF | 0.77% |
| XMHQ | Invesco S&P MidCap Quality ETF | 0.69% |
| FLQS | Franklin U.S. Small Cap Multifactor Index ETF | 0.64% |
| SEIS | SEI Exchange Traded Funds - SEI Select Small Cap ETF | 0.61% |
| PAPI | Parametric Equity Premium Income ETF | 0.60% |
Weight is the stock’s share of each fund’s holdings.
